Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
AbstractPalliative treatment concepts are considered in patients with non-curatively resectable and/or metastasized pancreatic cancer. However, patients without metastases, but presented with marginally resectable or locally non-resectable tumors should not be treated by a palliative therapeutic approach. These patients should be enrolled in neoadjuvant radiochemotherapy trials because a potentially curative resection can be achieved in approximately one-third of them after finishing treatment and restaging. Within the scope of best possible palliative care, resection of the primary cancer together with excision of metastases represents a therapeutic option to be contemplated in selected cases. Comprehensive palliative therapy is based on treatment of bile duct or duodenal obstruction for certain locally unresectable or metastasized advanced pancreatic cancer. However, endoscopic or percutaneous stenting procedures and surgical bypass provide safe and highly effective therapeutic alternatives. In case of operative drainage of the biliary tract (biliodigestive anastomosis), the prophylactic creation of a gastro-intestinal bypass (double bypass) is recommended. The decision to perform a surgical versus an endoscopic procedure for palliation depends to a great extent on the tumor stage and the estimated prognosis, and should be determined by an interdisciplinary team for each patient individually. View Full-Text
Share & Cite This Article
Assfalg, V.; Hüser, N.; Michalski, C.; Gillen, S.; Kleeff, J.; Friess, H. Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer. Cancers 2011, 3, 652-661.
Assfalg V, Hüser N, Michalski C, Gillen S, Kleeff J, Friess H. Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer. Cancers. 2011; 3(1):652-661.Chicago/Turabian Style
Assfalg, Volker; Hüser, Norbert; Michalski, Christoph; Gillen, Sonja; Kleeff, Jorg; Friess, Helmut. 2011. "Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer." Cancers 3, no. 1: 652-661.